CONTINUUS Pharmaceuticals Raises $5 M in Series B Round, Led by Mark Bamforth Who Will Join the Board of Directors
- CONTINUUS Pharma
- Sep 5, 2019
- 1 min read
Updated: Aug 7, 2024
Thursday, September 5th, 2019 - General News,Press Release
This round was led by Mark Bamforth, President & CEO at Arranta Bio, with participation by IMA Industria Macchine Automatiche and other investors from previous rounds. Bamforth will also join the Board of Directors of CONTINUUS, bringing decades of experience in commercial pharmaceutical manufacturing. Find the full press release here
Comments